Alumis (ALMS) said Tuesday its shareholders approved its pending merger with Acelyrin (SLRN) at a special shareholder meeting.
Separately, Acelyrin also said its stockholders approved its merger agreement with Alumis at a special meeting. Acelyrin stockholders will receive 0.4814 shares of Alumis stock for each Acelyrin share.
They expect to close the merger in the second quarter.
Price: 4.83, Change: -0.42, Percent Change: -8.00